ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Checkmate Pharmaceuticals Inc

Checkmate Pharmaceuticals Inc (CMPI)

10.50
0.00
(0.00%)
Closed September 23 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
10.50
Bid
10.50
Ask
10.50
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
10.50
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CMPI Latest News

University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its proprietary...

Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary...

Checkmate Pharmaceuticals Shares Take Flight on Regeneron Deal

By Colin Kellaher Shares of Checkmate Pharmaceuticals Inc. more than quadrupled in premarket trading Tuesday after the clinical-stage biopharmaceutical company agreed to be acquired by Regeneron...

Regeneron to Buy Checkmate Pharmaceuticals for About $250 Million

By Colin Kellaher Regeneron Pharmaceuticals Inc. on Tuesday said it agreed to buy clinical-stage biopharmaceutical company Checkmate Pharmaceuticals Inc. for about $250 million in a deal that...

Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types

Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types PR Newswire TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 19, 2022...

Checkmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual Meeting

CAMBRIDGE, Mass., April 08, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its...

Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business Update

Alan Bash, experienced biopharmaceutical executive, appointed President and CEO Clinical trials with vidutolimod (CMP-001) in melanoma, head and neck cancer indications ongoing; Trial dosing...

Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting

CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its...

Checkmate Pharmaceuticals Appoints Alan Bash as President and CEO

CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.15
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.87
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.93
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5103
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.15
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.87
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.93
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5103
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.15
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.87
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.93
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5103
(0.00%)
0

CMPI Discussion

View Posts
hedge_fun hedge_fun 2 years ago
Geez, I simply congratulated longs but now.......

I’m being asked to be a motivational speaker.

Amusing
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
How much PROFIT did you make, Dude??? Inspire us!! Heck with the champaigne --- our men need NUMBERS!
👍️0
hedge_fun hedge_fun 2 years ago
Congrats longs. Pop the champagne and.......

pour me a glass, please.
👍️0
TheFinalCD TheFinalCD 2 years ago
*CHECKMATE*
👍️0
Awl416 Awl416 2 years ago
Congrats
👍️0
crudeoil24 crudeoil24 2 years ago
Regeneron to Buy Checkmate Pharmaceuticals for About $250 Million >REGN CMPI
7:17 am ET April 19, 2022 (Dow Jones) Print

By Colin Kellaher


Regeneron Pharmaceuticals Inc. on Tuesday said it agreed to buy clinical-stage biopharmaceutical company Checkmate Pharmaceuticals Inc. for about $250 million in a deal that bolsters Regeneron's portfolio of diverse and combinable immuno-oncology candidates.

Regeneron said it will pay $10.50 a share in cash for Checkmate, more than four times Monday's closing price of $2.41 for the Cambridge, Mass., company.

Regeneron said Checkmate's lead investigational asset, vidutolimod, is currently being studied in combination with other agents for melanoma, nonmelanoma skin cancers, and head and neck cancer.

The Tarrytown, N.Y., biotechnology company said it expects to complete the acquisition around the middle of the year.

Trading in shares of Checkmate was halted premarket Tuesday.
👍️0
BlazingStocks BlazingStocks 3 years ago
$CMPI had it's highest volume in a year, let's see what happens next. We could be getting an update soon.
👍️0
BlazingStocks BlazingStocks 3 years ago
Great $CMPI volume heading into Power Hour!
👍️0
BlazingStocks BlazingStocks 3 years ago
$CMPI posted an 8-k pertaining to the Shareholders Meeting...

https://last10k.com/sec-filings/cmpi/0001193125-21-194290.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=cmpi
👍️0
BlazingStocks BlazingStocks 3 years ago
$CMPI trading over 25% of its 10-day average volume in the first 80 minutes!
👍️0
BlazingStocks BlazingStocks 3 years ago
Let's see if the $CMPI chart can make a reversal and then continue its plot upwards...
👍️0
wildstock wildstock 3 years ago
$CMPI Strong support level @ 6$ https://www.barchart.com/stocks/quotes/CMPI/cheat-sheet
👍️0
wildstock wildstock 3 years ago
$CMPI Barchart opinion looks oversold see here - https://www.barchart.com/stocks/quotes/CMPI/opinion
👍️0
wildstock wildstock 3 years ago
$CMPI daily chart poised for a breakout soon https://stockcharts.com/h-sc/ui?s=CMPI
👍️0
BlazingStocks BlazingStocks 3 years ago
$CMPI trading at 25% of its 10-day average volume...in the first hour!
👍️0
BlazingStocks BlazingStocks 3 years ago
$CMPI has a 10-day average volume of almost 26k but has been trading at that level or higher for the past month.
👍️0
BlazingStocks BlazingStocks 3 years ago
$CMPI News May 13, 2021

Checkmate Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Update on Recent Progress
https://finance.yahoo.com/news/checkmate-pharmaceuticals-reports-first-quarter-201000665.html
👍️0
jedijazz jedijazz 3 years ago
$CMPI Checkmate Pharmaceuticals Releases Clinical Data For Vidutolimod And Pembrolizumab Combo

https://www.nasdaq.com/articles/checkmate-pharmaceuticals-releases-clinical-data-for-vidutolimod-and-pembrolizumab-combo
👍️0
wildstock wildstock 3 years ago

$CMPI Recent News : Checkmate Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
https://finance.yahoo.com/news/checkmate-pharmaceuticals-present-jefferies-2021-203000628.html
👍️0
wildstock wildstock 3 years ago
$CMPI Gallery View https://stockcharts.com/freecharts/gallery.html?CMPI
👍️0

Your Recent History

Delayed Upgrade Clock